• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

BioAlliance Pharma SA

+ Add to Watchlist

C4X:GR

8.130 EUR 0.380 4.90%

As of 03:09:52 ET on 04/24/2014.

Snapshot for BioAlliance Pharma SA (C4X)

Open: 8.125 Day's Range: 8.058 - 8.130 Volume: 0
Previous Close: 7.750 52wk Range: 2.999 - 10.700 1-Yr Rtn: +95.07%

Stock Chart for C4X

No chart data available.
  • C4X:GR 8.130
  • 1D
  • 1M
  • 1Y
7.750
Interactive C4X Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C4X

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 135.5000
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.0600
Est. PEG Ratio -
Market Cap (M EUR) 164.06
Shares Outstanding (M) 20.18
30 Day Average Volume 201
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/19/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C4X

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for C4X

BioAlliance Pharma is a biopharmaceutical company specialized in the development of therapeutics targeting drug resistance in cancer, HIV and other severe and opportunistic infections. The Company addresses worldwide markets in the EU, US and Asia.

Patrick J LangloisChairmanJudith Christine GrecietChief Executive Officer
Pierre AttaliChief Operating OfficerNicolas FellmannVP/Chief Financial Officer
More Company Profile & Key Executives for C4X

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil